
Alan Brennan
Articles
-
Mar 12, 2024 |
drc.bmj.com | Laura Heathcote |Daniel Pollard |Alan Brennan |Melanie J. Davies
WHAT IS ALREADY KNOWN ON THIS TOPICHOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE, OR POLICYIntroductionIt is estimated that diabetes affects just under half a billion people worldwide, of whom approximately 90% in high-income countries have type 2 diabetes (T2D).1 People with T2D have an elevated risk of developing serious complications such as renal failure, blindness, amputation, cardiovascular disease (CVD), depression, and osteoarthritis.
-
Mar 1, 2024 |
drc.bmj.com | Laura Heathcote |Daniel Pollard |Alan Brennan |Melanie J. Davies
MethodsThis analysis was a lifetime horizon, model-based cost-utility analysis using the School for Public Health Research (SPHR) Diabetes Prevention Model v3.2 (hereafter referred to as “the model”),19 20 as prespecified in the PROPELS health economics analysis plan. A model-based analysis was conducted for two reasons.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →